A detailed history of Brown, Lisle/Cummings, Inc. transactions in Danaher Corp stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 2,322 shares of DHR stock, worth $511,861. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,322
Previous 2,372 2.11%
Holding current value
$511,861
Previous $469 Million 1.75%
% of portfolio
0.12%
Previous 0.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 10, 2025

SELL
$181.46 - $212.2 $9,073 - $10,610
-50 Reduced 2.11%
2,322 $460 Million
Q2 2025

Jul 16, 2025

SELL
$174.64 - $205.16 $28,815 - $33,851
-165 Reduced 6.5%
2,372 $469 Million
Q1 2025

Apr 22, 2025

BUY
$201.62 - $250.59 $15,121 - $18,794
75 Added 3.05%
2,537 $520 Million
Q4 2024

Jan 24, 2025

SELL
$226.16 - $274.52 $76,668 - $93,062
-339 Reduced 12.1%
2,462 $565 Million
Q3 2024

Oct 18, 2024

BUY
$239.25 - $280.76 $118,428 - $138,976
495 Added 21.47%
2,801 $779 Million
Q2 2024

Jul 17, 2024

BUY
$235.51 - $267.98 $5,887 - $6,699
25 Added 1.1%
2,306 $576 Million
Q4 2023

Jun 28, 2024

SELL
$185.1 - $233.13 $141,601 - $178,344
-765 Reduced 25.11%
2,281 $528 Million
Q3 2023

Jun 28, 2024

BUY
$233.08 - $265.59 $6,992 - $7,967
30 Added 0.99%
3,046 $756 Million
Q2 2023

Jun 28, 2024

BUY
$224.99 - $256.14 $7,874 - $8,964
35 Added 1.17%
3,016 $724 Million
Q4 2022

Jun 28, 2024

BUY
$241.42 - $282.29 $120,710 - $141,145
500 Added 20.15%
2,981 $791 Million
Q3 2022

Jun 28, 2024

BUY
$247.06 - $1507.4 $6,176 - $37,685
25 Added 1.02%
2,481 $641 Million
Q2 2022

Jun 28, 2024

BUY
$237.11 - $299.66 $5,927 - $7,491
25 Added 1.03%
2,456 $623 Million
Q1 2022

Jun 28, 2024

BUY
$257.27 - $315.76 $347,571 - $426,591
1,351 Added 125.09%
2,431 $713 Million
Q4 2021

Jun 28, 2024

BUY
$292.08 - $329.01 $315,446 - $355,330
1,080 New
1,080 $355 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $160B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Brown, Lisle/Cummings, Inc. Portfolio

Follow Brown, Lisle/Cummings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.